Josh Gottheimer bought Sarepta Therapeutics Inc (NASDAQ: SRPT)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 5 trades in Sarepta Therapeutics Inc (SRPT) since 2019, 3 purchases and 2 sales, worth an estimated $40K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Josh Gottheimer bought $1,001 - $15,000 of Sarepta Therapeutics Inc (NASDAQ: SRPT) on March 6, 2023. Since that trade, SRPT is down -90.04% against the S&P 500 up +88.13%, an outperformance of -178.17%.
Across these filings, Josh Gottheimer has been a net buyer of SRPT (a buy-to-sell ratio of 1.50). The most recent disclosed SRPT transaction shown was dated July 14, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Josh Gottheimer's SRPT trades vs the price
SRPT is down -90.04% since Josh Gottheimer bought on March 6, 2023, versus +88.13% for the S&P 500.
Performance since this trade
All Josh Gottheimer SRPT trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Josh Gottheimer & SRPT trading FAQ
Is it legal for Josh Gottheimer to trade Sarepta Therapeutics Inc (SRPT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Sarepta Therapeutics Inc (SRPT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer buy SRPT?
Josh Gottheimer disclosed a purchase of $1,001 - $15,000 of Sarepta Therapeutics Inc (SRPT) on March 6, 2023, according to public STOCK Act filings.
How has SRPT performed since Josh Gottheimer's trade?
Since Josh Gottheimer bought SRPT on March 6, 2023, the stock is down -90.04%, versus +88.13% for the S&P 500 over the same period, an outperformance of -178.17%.
How many times has Josh Gottheimer traded SRPT?
Josh Gottheimer has disclosed 5 SRPT trades since 2019 (3 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SRPT trades?
Quantellect tracks every disclosed congressional trade in Sarepta Therapeutics Inc (SRPT) on the Sarepta Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's SRPT tradesAll congressional filings for Sarepta Therapeutics IncJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.